Increase of nuclear phosphatidylinositol 4,5-bisphosphate and phospholipase C β1 is not associated to variations of protein kinase C in multidrug-resistant Saos-2 cells

Microscopy Research and Technique

Volumn 36, Issue 3, 1997, Pages 172-178

  Zini, Nicoletta ^a   Neri, Luca M ^a,b   Ognibene, Andrea ^c   Scotlandi, Katia ^d   Baldini, Nicola ^d   Maraldi, Nadir M ^a,c,e  

^a CNR   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c Lab Biol Cell Microscopia E   (Italy)

^d RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

human osteosarcoma; immunocytochemistry; nuclear signal transduction; P glycoprotein; polyphosphoinositides

Indexed keywords

BACTERIOPHAGES; CELL CULTURE; CELL MEMBRANES; ENZYMES; GLYCOPROTEINS; PHOSPHOLIPIDS;

5-BISPHOSPHATE; HUMAN OSTEOSARCOMA; IMMUNOCYTOCHEMISTRY; MULTIDRUG RESISTANCE; NUCLEAR SIGNAL TRANSDUCTION; P-GLYCOPROTEIN; PHOSPHATIDYLINOSITOL 4; PHOSPHOLIPASE C; POLYPHOSPHOINOSITIDE; PROTEIN KINASES C;

SIGNAL TRANSDUCTION;

GLYCOPROTEIN P; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C; PROTEIN KINASE C;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; OSTEOSARCOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0030891451     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0029(19970201)36:3<172::AID-JEMT5>3.0.CO;2-R     Document Type: Article

References (62)

1. Ahmad, S., Trepel, J., Ohno, S., Suzuki, T., Tsuruo, T., and Glazer, R. (1992) Role of protein kinase C in the modulation of multidrug resistance: Expression of the atypical γ isoform of protein kinase C does not confer increased resistance to doxorubcin. Mol. Pharmacol., 42:1004-1009.
2. Anderson, L., Cummings, J., Bradshaw, T., and Smyth, J. (1991) The role of protein kinase C and the phosphatidylinositol cycle in multidrug resistance in human ovarian cancer cells. Biochem. Pharmacol., 42:1427-1432.
3. Aquino, A., Hartman, K.D., Knode, M.C., Grant, S., Huang, K.P., Niu, C.H., and Glazer, R.I. (1988) Role of protein kinase C in phosphorylation of vinculin in adriamycin resistant HL-60 leukemic cells. Cancer Res., 448:3324-3329.
4. Baldini, N., Scotlandi, K., Serra, M., Shikita, T., Zini, N., Ognibene, A., Santi, S., Ferracini, R., and Maraldi, N.M. (1995) Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Eur. J. Cell Biol., 68:226-239.
5. Banfic, H., Zizak, M., Divecha, N., and Irvine, R.F. (1993) Nuclear diacylglycerol is increased during cell proliferation in vivo. Biochem. J., 290:633-636.
6. Batist, G., Tulpule, A., Sinha, B.K., Kathi, A.G., Myers, C.E., and Cowan, K.H. (1986) Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem., 261:15544-15549.
7. Blobe, G., Sachs, C., Khan, W., Fabbro, D., Stabel, S., Wetsel, W., Obeid, L., Fine, R., and Hannun, Y. (1993) Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells: Functional significance of enhanced expression of PKC α. J. Biol. Chem., 26:658-664.
8. Bradley, G., Naik, M., and Ling, V. (1989) P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines. Cancer Res., 4:2790-2796.
9. Buchner, K. (1995) Protein kinase C in the transduction of signals toward and within the cell nucleus. Eur. J. Biochem., 228:211-221.
10. Chambers, T.C., Chalikonda, I., and Eilon, G. (1990) Correlation between protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug-resistant human KB cells. Biochem. Biophys. Res. Commun., 16:253-259.
11. Cornwell, M.M., Safa, A.R., Feisted, R.L., Gottesman, M.M., and Pastan, I. (1986) Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150-to 170-kDa protein detected by photoaffinity labeling. Proc. Natl. Acad. Sci. U.S.A., 83:3847-3850.
12. Cowan, K.H., Batist, G., Tulpule, A., Sinha, B.K., and Myers, C.E. (1986) Similar biochemical changes associated with multidrug-resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc. Natl. Acad. Sci. U.S.A., 83:9328-9332.
13. Divecha, N., Rhee, S.G., Letcher, A.J., and Irvine, R.F. (1993) Phosphoinositide signalling enzymes in rat liver nuclei: Phosphoinositidase C isoform β1 is specifically but not predominantly, located in the nucleus. Biochem. J., 289:617-620.
14. Durrenberger, M., Bjornsti, M.A., Uetz, T., Hobot, J., and Kellenberger, E. (1988) Intracellular location of the histone-like protein HU inEscherichia coli. J. Bacteriol., 170:4757-1768.
15. Endicott, J.A., and Ling, V. (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58:137-171.
16. Epand, R.M., and Stafford, A.R. (1993) Protein kinases and multidrug resistance. Cancer J., 6:154-157.
17. Fan, D., Fidler, I., Ward, N., Seid, C., Earnest, L., Housey, G., and O'Brian, C. (1992) Stable expression of a cDNA encoding rat brain protein kinase C-βI confers a multidrug-resistant phenotype on rat fibroblasts. Anticancer Res., 12:661-668.
18. Ferguson, P.J., and Cheng, Y.C. (1987) Transient protection of cultured human cells against antitumor agents by 12-O-tetradecanoyl-13-acetate. Cancer Res., 47:433-441.
19. 3H inositol and incorporation into phosphatidylinositols (PI) and hydrolysis of PI in multidrug resistant (MDR) MCF-7 cells. Proc. Am. Assoc. Cancer Res., 28:291.
20. Fine, R.L., Patel, J., and Chabner, B.A. (1988) Phorbol esters induce multidrug resistance in human breast cancer cells. Proc. Natl. Acad. Sci. U.S.A., 85:582-586.
21. Gollapudi, S., Patel, K., Jain, V., and Gupta, S. (1992) Protein kinase C isoforms in multidrug resistant P388/ADR cells: A possible role in daunorubicin transport. Cancer Lett., 62:69-75.
22. Gottesman, M.M., and Pastan, I. (1988) The multidrug transporter, a double-edged sword. J. Biol. Chem., 263:12163-12166.
23. Greenberger, L.M., Lothstein, L., Williams, S.S., and Horrwitz, S.B. (1988) Distinct P-glycoprotein precursors are overproduced in independently isolated drug-resistant cell lines. Proc. Natl. Acad. Sci. U.S.A., 85:3762-3766.
24. Hagiwara, M., Wakusawa, S., Miyamoto, K., and Hikada, H. (1991) Obviation of drug resistance and affinity purification of P-glycoprotein by isoquinolinesulfonamides. Cancer Lett., 60:103-107.
25. r 170,000 glycoprotein specific to multidrug-resistant tumor cells: Effects of verapamil, trifluoperazine and phorbol esters. Cancer Res., 47:2860-2865.
26. Hamilton, T.C., Winkler, M.A., Louie, K.G., Batist, G., Beherens, B., Tsuruo, T., Grotzinger, K.R., McKoy, W.M., Young, R.C., and Ozols, R.F. (1985) Augmentation of Adriamycin, melphalan and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian cancer cell lines by buthionine sulfoximine-mediated glutathione depletion. Biochem. Pharmacol., 344:2583-2589.
27. Higgins, C.F., and Gottesman, M.M. (1992) Is the multidrug transporter a flippase? Trends Biochem. Sci., 17:18-21.
28. Hirai, M., Gamou, S., Kobayashi, M., and Shimizu, N. (1989) Lung cancer cells often express high levels of protein kinase C activity. Jpn. J. Cancer Res., 80:204-208.
29. Kessel, D. (1987) Effects of phorbol esters and doxorubicin transport systems. Biochem. Pharmacol., 37:2297-2299.
30. Lee, S.A., Karaszkiewicz, J.W., and Anderson, W.A. (1992) Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Res., 52:3750-3759.
31. 2 hydrolysis and regulation of phospholipase C isozymes. Curr. Opin. Cell Biol., 7:183-189.
32. Maraldi, N.M., Zini, N., Santi, S., Bavelloni, A., Valmori, A., Marmiroli, S., and Ognibene, A. (1993) Phosphoinositidase C isozymes in Saos-2 cells: Immunocytochemical detection in nuclear and cytoplasmic compartments. Biol. Cell., 79:243-250.
33. 1 in cells exposed to mitogenic or differentiating agonists. Biol. Cell., 83:201-210.
34. 580 multidrug-resistant human osteosarcoma cells. J. Submicr. Cytol., 28:1-5.
35. Marmiroli, S., Ognibene, A., Bavelloni, A., Cinti, C., Cocco, L., and Maraldi, N.M. (1994) Interleukin 1α stimulated nuclear phosphoinositidase C in human osteosarcoma Saos-2 cells. J. Biol. Chem., 269:1-4.
36. 1 in Swiss 3T3 cells. Nature, 358:242-245.
37. Mazzoni, M., Bertagnolo, V., Neri, L.M., Carini, C., Marchisio, M., Milani, D., Manzoli, F.A., and Capitani, S. (1992) Discrete subcellular localization of phosphoinositidase C β, γ and δ in PC12 rat pheochromocytoma cells. Biochem. Biophys. Res. Commun., 187:114-120.
38. Mazzotti, G., Zini, N., Rizzi, E., Rizzoli, R., Galanzi, A., Ognibene, A., Santi, S., Matteucci, A., Martelli, A.M., and Maraldi, N.M. (1995) Immunocytochemical detection of phosphatidylinositol 4,5-bisphosphate localization sites within the nucleus. J. Histochem. Cytochem., 43:181-191.
39. Mimnaugh, E.G., Dusre, L., Atwell, J., and Myers, C.E. (1989) Differential oxygen radical susceptibility of Ardiamycin-sensitive and -resistant MCF-7 human breast tumor cells. Cancer Res., 49:8-15.
40. Mungikar, A., Chitnis, M., and Gothoskar, B. (1981) Mixed function oxidase enzymes in Ardiamycin-sensitive and -resistant sublines of P388 leukemia. Chem. Biol. Interact., 35:119-124.
41. Neri, L.M., Milani, D., Marchisio, M., Bertolaso, L., Marinelli, F., Manzoli, F.A., and Capitani, S. (1993) Immunocytochemical analysis of phosphatidylinositol-specific phospholipase C in PC12 cells: Predominance of the δ isoform during neural differentiation. Histochemistry, 100:121-129.
42. Niedal, J.E., Kuhn, L.J., and Vandenbark, G.R. (1983) Phorbol diester receptor copurifies with protein kinase C. Proc. Natl. Acad. Sci. U.S.A., 80:36-40.
43. O'Brian, C.A., Fan, D., Ward, N.B., Seid, C., and Fidler, I.J. (1989) Level of protein kinase C activity correlates directly with resistance to Ardiamycin in murine fibrosarcoma cells. FEBS Lett., 246:78-82.
44. Ognibene, A., Bavelloni, A., Faenza, I., Cecchi, S., Marmiroli, S., and Maraldi, N.M. (1995) Interleukin 1α activates PKC of Saos-2 osteosarcoma cells. III Workshop on Osteobiology, July 1-3, 1995, Mattinata, Italy, 63 (abstract).
45. Pastan, I., and Gottesman, M. (1987) Multiple-drug resistance in human cancer. Engl. J. Med., 316:1388-1393.
46. Posada, J., McKeegan, E., Worthington, K., Morin, M., Jaken, S., and Tritton, T. (1989) Human multidrug resistant KB cells overexpress protein kinase C: Involvement in drug resistance. Cancer Commun., 1:285-292.
47. Ramu, A., Glaubiger, D., and Weintraub, H. (1984) Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells. Cancer Treat. Rep., 68:637-641.
48. Sato, W., Yusa, K., Naito, M., and Tsuruo, T. (1990) Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cells. Biochem. Biophys. Res. Commun., 173:1252-1257.
49. Schwartz, G., Arkin, H., Holland, J., and Ohnuma, T. (1991) Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimethotrexate. Cancer Res., 51:55-61.
50. Serra, M., Scotlandi, K., Manara, M.C., Maurici, D., Lollini, P.L., De Giovanni, C., Toffoli, G., and Baldini, N. (1993) Establishment and characterization of multidrug-resistant human osteosarcoma cell lines. Anticancer Res., 13:323-330.
51. Somfai-Rene, S., Suzukake, K., Vistica, B.P., and Vistica, D.T. (1984) Reduction in cellular glutathione by buthionine sulfoximme and sensitization of murine tumor cells resistant to L-phenylalanine mustard. Biochem. Pharmacol., 33:485-490.
52. Staats, J., Marquardt, D., and Center, M. (1990) Characterization of a membrane-associated protein kinase of multidrug-resistant HL60 cells which phosphorylates P-glycoprotein. J. Biol. Chem., 265:4084-4090.
53. Tapiero, H., Mishal, Z., Wioland, A., Silber, A., Fourcade, A., and Zwingelstein, G. (1989) Changes in biophysical parameters and in phospholipid composition associated with resistance to doxorubicin. Anticancer Res., 6:649-652.
54. Tew, K.D., Moy, B.C., and Hartley-Asp, B. (1983) Acquired drug resistance is accompanied by modification in the karyotype and nuclear matrix of a rat carcinoma cell line. Exp. Cell Res., 149:443-450.
55. Vrignaud, P., Montaudon, D., Londos-Gagliardi, D., and Robert, J. (1986) Fatty acid composition, transport and metabolism in doxorubicin-sensitive and -resistant rat glioblastoma cells. Cancer Res., 46:3258-3261.
56. Ward, N., and O'Brian, C. (1991) Distinct patterns of phorbol ester-induced downregulation of protein kinase C activity in adriamycin-selected multidrug resistant and parental murine fibrosarcoma cells. Cancer Lett., 58:189-193.
57. Yu, G., Ahmad, S., Aquino, A., Fairchild, C.R., Trepel, J., Ohno, S., Ohno, K., Suzuki, T., Tsuruo, T., Cowan, K., and Glazer, R. (1991) Transfection with protein kinase C α confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun., 3:181-189.
58. Yu, F.X., Sun, H.Q., Janney, P.A., and Yin, H.L. (1992) Identification of a polyphosphoinositide-binding sequence in an actin monomer-binding domain of gelsolin. J. Biol. Chem., 287:14616-14625.
59. Zini, N., Martelli, A.M., Cocco, L., Manzoli, F.A., and Maraldi, N.M. (1993) Phosphoinositidase C isoforms are specifically localized in the nuclear matrix and cytoskeleton of Swiss 3T3 cells. Exp. Cell Res., 208:257-269.
60. 1 isoform is not affected. Eur. J. Cell Biol., 68:25-34.
61. Zini, N., Martelli, A.M., Neri, L.M., Bavelloni, A., Sabatelli, P., Santi, S., and Maraldi, N.M. (1995b) Immunocytochemical evaluation of protein kinase C translocation to the inner nuclear matrix in 3T3 mouse fibroblasts after IGF-I treatment. Histochemistry, 103:447-457.
62. Zini, N., Scotlandi, K., Baldini, N., Nini, G., Sabatelli, P., and Maraldi, N.M. (1995c) Multidrug-resistance (MDR) phenotype of human osteosarcoma cells evaluated by quantitative morphological and electron microscopy analyses. Biol. Cell, 84:195-204.